UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. SynCardia CardioWest TAH-t Postmarket Surveillance Study
    Jennifer Goerbig-Campbell
  2. RTOG 1010: A phase III trial evaluating the addition of trastuzumab to trimodality treatment of HER2-overexpressing esophageal adenocarinoma
    Mark C. Smith
  3. A randomized double-blinded phase III study comparing gemcitabine, cisplatin, and bevacizumab (IND #7921, NSC #704865) to gemcitabine, cisplatin, and placebo in patients with advanced transitional cel…
    Daniel Vaena
  4. A randomized double-blind, placebo-controlled study of LEE011 in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive, HER2-negative, advanced breast can…
    Alexandra Thomas
  5. Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program (PAH QuERI Ext)
    Linda Cadaret
  6. Safety Study of Ambrisentan in Subjects With Pulmonary Hypertension
    Alicia Gerke
  7. Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
    Ayman El-Sheikh
  8. A Phase 3, Randomized, Placebo-Controlled, Parallel-Group, Multicenter, Double-blind Study to Evaluate the Efficacy and Safety of Telotristat Etiprate (LX1606) in Patients with Carcinoid Syndrome Refr…
    Joseph Dillon
  9. Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy®) in Patients...
    Mohammed Milhem
  10. Study to Compare Cancer Treating Drugs
    Mohammed Milhem
  11. Molecular Pathways in Cardiovascular Disease
    Frances Johnson
  12. A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endome…
    David Bender
  13. Randomized Controlled Study Comparing AEZS-108 with Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer
    David Bender
  14. A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer following Fir…
    David Bender
  15. Interactionality of State-Trait Music Preference, Individual Variability, and Music Characteristics as a Multi-Axis Paradigm for Context...
    Xueli Tan
  16. A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: THE OUTBACK TRIAL
    David Bender
  17. A Randomized Phase II Study of Temozolomide or Temozolomide and Capecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors
    Daniel Vaena
  18. A Randomized, Open-label, Phase II, Multi-center Trial of Gemcitabine (G) with Pazopanib (P) or Gemcitabine (G) with Docetaxel (T) in Previously Treated Subjects with Advanced Soft Tissue Sarcoma
    Mohammed Milhem
  19. A Multicenter Open-Label, Randomized Phase 1b/2, Study of the Bruton
    Brian Link
  20. RTOG 1008: A randomized phase II study of adjuvant concurrent radiation and chemotherapy versus radiation alone in
    Mark C. Smith

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.